No abstract available
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / secondary
-
Aged
-
Antibodies, Monoclonal / therapeutic use*
-
Antineoplastic Agents / therapeutic use*
-
Duodenal Neoplasms / drug therapy*
-
Humans
-
Kidney Transplantation*
-
Liver Neoplasms / secondary
-
Male
-
Nivolumab
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
Substances
-
Antibodies, Monoclonal
-
Antineoplastic Agents
-
Programmed Cell Death 1 Receptor
-
Nivolumab